GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
115 hedge funds and large institutions have $184M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 45 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 45
Holders
115
Holding in Top 10
–
Calls
$1.24M
Puts
$636K
Top Buyers
| 1 | +$3.58M | |
| 2 | +$2.45M | |
| 3 | +$1.94M | |
| 4 |
PCM
Pinz Capital Management
New York
|
+$1.77M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$1.58M |
Top Sellers
| 1 | -$6.25M | |
| 2 | -$5.93M | |
| 3 | -$5.89M | |
| 4 |
LOAMS
Lombard Odier Asset Management (Switzerland)
Petit-Lancy,
Switzerland
|
-$4.82M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$4.73M |